|
|
Home > Health
Conditions > Crohn's Disease
Crohn’s Disease/IBD/Colitis
Popular Supplements:
Alternative News:
-
Eating Fruits and
Vegetables Cuts Risk for Crohn's Disease - Medscape, 5/1/23 -
"people who consumed large amounts of unprocessed or
minimally processed food (the highest quartile) were half as likely to develop
Crohn's disease (hazard ratio [HR] = 0.57; 95% CI, 0.35–0.93) in comparison with
people who consumed the least amounts of these types of food (lowest quartile).
This outcome was especially significant for fruits and vegetables"
-
Ginkgo biloba Extract
Preventively Intervenes in Citrobacter Rodentium-Induced Colitis in Mice -
Nutrients 2023 Apr 21 - "Citrobacter Rodentium
(CR)-induced mouse colitis ... The results of our studies revealed that
pre-treatment with GBE was sufficient for protecting the animals from CR-induced
colitis. As a mechanism for GBE activity, GBE treatment was able to modulate the
intestinal microbiota and increase the SCFAs capable of decreasing the
pro-inflammatory factors and up-regulating the anti-inflammatory factors while
elevating the intestinal-barrier-associated proteins to maintain the integrity
of the intestines. Accordingly, our results led to a strong suggestion that GBE
should be seriously considered in the preventive control of CR-induced colitis
and in the development of effective and safe therapeutic strategies for
controlling IBD" - See
Ginkgo biloba at Amazon.com.
-
The effects of live and
pasteurized Akkermansia muciniphila on DSS-induced ulcerative colitis, gut
microbiota, and metabolomics in mice - Food Funct 2023 Apr 26 -
"Notably, prophylactic supplementation of pasteurized A.
muciniphila increased the relative abundance of the anti-inflammatory microbe
Dubosiella, thereby activating intestinal sphingolipid metabolism to alleviate
intestinal damage. In conclusion, pasteurized A. muciniphila showed a more
effective amelioration of DSS-induced colitis by repairing the dysbiosis of gut
microbiota and intestinal metabolism compared to live A. muciniphila, providing
a potential strategy to explore the protective effect of A. muciniphila on host
intestinal health" - See Akkermansia
muciniphila at Amazon.com.
-
The synergistic effect of
epigallocatechin-3-gallate and quercetin co-loaded hydrogel beads on
inflammatory bowel disease - Food Funct 2023 Apr 17 -
"The synergistic effect of epigallocatechin-3-gallate
(E) and quercetin (Q) enhances the therapeutic efficacy on related diseases;
however, the instability and lower bioavailability of E and Q limited their
application. Therefore, E and Q were co-encapsulated in hydrogel beads (H) with
sodium alginate (SA) and soybean protein isolate (SPI) to improve their
stability and bioavailability ... This study provides a theoretical basis for
the application of E and Q in IBD" - See
green tea extract at Amazon.com and
quercetin at Amazon.com.
-
Ginsenoside Rg3 Ameliorates
DSS-Induced Colitis by Inhibiting NLRP3 Inflammasome Activation and Regulating
Microbial Homeostasis - J Agric Food Chem 2023 Feb 8 -
"Ulcerative colitis (UC) is a recurrent inflammatory
disease without a specific cure or treatment for improvement. Here, we
investigated the potential therapeutic effect and mechanism of ginsenoside Rg3
(Gin Rg3) on UC ... In summary, Gin Rg3 alleviated DSS-induced UC by inhibiting
NLRP3 inflammasome activation and regulating gut microbiota homeostasis"
- See ginseng at Amazon.com.
-
Herbal Combination Tames
Active Ulcerative Colitis: Study - Medscape, 2/2/23 -
"Among 42 patients
randomized on a 2:1 basis to receive either an enteric-coated pill containing 3
g of curcumin and qing-dai (CurQD) or placebo for 8 weeks, 43% of those assigned
to receive the combination met the co-primary endpoint of a significant
reduction in disease activity and objective evidence of response, compared with
8% of those assigned to placebo" - See
curcumin at Amazon.com and
qing-dai at Amazon.com.
-
Pancreatic enzyme
supplementation versus placebo for improvement of gastrointestinal symptoms
in non-responsive celiac disease: A cross-over randomized controlled trial
- Front Med (Lausanne) 2023 Jan 4 - "Pancreatic
Exocrine Insufficiency (PEI) is a possible cause of recurrent/persistent
symptoms in celiac disease. Although pancreatic enzyme supplementation may
be used to treat non-responsive celiac disease (NRCD) in clinical practice,
clinical outcomes are variable and there is limited and low quality evidence
to support this practice. The aim of this study was to assess the efficacy
of pancreatic enzyme supplements (PES) for improvement of gastrointestinal
symptoms in NRCD ... In this prospective, cross-over randomized,
placebo-controlled study, PES did not improve symptoms in patients with
NRCD. It is unclear whether this is a trial effect or related to
administration of omeprazole."
-
Polysaccharides from
natural Cordyceps sinensis attenuated dextran sodium sulfate-induced colitis
in C57BL/6J mice - Food Funct 2023 Jan 4 - "As
potential candidates for treating ulcerative colitis (UC), polysaccharides
have been attracting extensive interest in recent years. Cordyceps sinensis
(C. sinensis) is a kind of traditional Chinese edible food, and its
polysaccharide fractions have been found to be effective in regulating
immunity and protecting the kidneys ... Results showed that the
polysaccharides significantly alleviated colitis by increasing the colon
length, alleviating colon tissue damage, and inhibiting the activation of
the NF-κB pathway. In addition, polysaccharides reduced the contents of
tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in the serum,
increased the number of goblet cells, and improved the expression of
intestinal tight junction proteins (Occludin and Claudin-1). They also
evidently enhanced the formation of IgA-secretory cells and sIgA contents.
Furthermore, the polysaccharides modulated the gut microbiota by decreasing
the relative abundance of Bilophila and increasing the relative abundance of
Dehalobacterium, Coprococcus, Oscillospira, and Desulfovibrio, which is
accompanied by an increase in the short chain fatty acids' (SCFAs)
concentrations in cecal contents. These results suggested that C. sinensis
polysaccharides possessed promising intervening effects on experimental
acute UC in mice" - See
cordyceps at Amazon.com.
-
Dietary Turmeric
Consumption Alleviates Ulcerative Colitis via Restoring Tryptophan
Metabolism and Alleviating Gut Microbiota Dysbiosis in Mice - J Agric
Food Chem 2022 Nov 22 - "Collectively, these
findings manifest the protective actions of dietary TP consumption against
ulcerative colitis via restoring the intestinal microbiota disorders,
promoting microbial metabolism, and improving intestinal barrier damage"
- See turmeric extract at Amazon.com.
-
Curcumin alleviates
LPS-induced intestinal homeostatic imbalance through reshaping gut microbiota
structure and regulating group 3 innate lymphoid cells in chickens - Food
Funct 2022 Oct 28 -"Gastrointestinal dysfunction is
associated with a disturbance of immune homeostasis, changes in the intestinal
microbiome, alteration of the composition of the bile acid pool, and dynamic
imbalance of group 3 innate lymphoid cells (ILC3s). Curcumin (CUR), a
polyphenolic compound isolated from turmeric, has been known to attenuate
intestinal inflammation in potential therapies for gastrointestinal disease ...
Dietary supplementation of CUR increased the prevalence of Butyricicoccus and
Enterococcus and enhanced the tricarboxylic acid cycle of intestinal epithelial
cells. In addition, curcumin supplementation significantly increased sirtuin 1
and sirtuin 5 transcription and protein expression, which contributes to
regulating mitochondrial metabolic and oxidative stress responses to alleviate
LPS-induced enteritis. Our findings demonstrated that curcumin played a pivotal
role in regulating the structure of the intestinal microbiome for health
promotion and the treatment of intestinal dysbiosis. The beneficial effects of
CUR may be attributed to the modulation of the BA-FXR pathway and inhibition of
inflammation that induces IL-22 secretion by ILC3s in the intestinal lamina
propria" - See curcumin at Amazon.com.
-
Pterostilbene Prevents
Tunicamycin-Induced Intestinal Barrier Damage by Targeting Endoplasmic Reticulum
Stress, Oxidative Stress, Autophagy, and Gut Microbiota - J Agric Food Chem
2022 Oct 12 - "Endoplasmic reticulum (ER) stress is a
crucial factor in the pathogenesis of intestinal diseases. Pterostilbene (PT)
has been demonstrated to mitigate ER stress and protect against intestinal
disorders ... In conclusion, PT alleviated TM-induced intestinal barrier damage
by regulating ER homeostasis, oxidative stress, autophagic flux, and gut
microbiota" - See pterostilbene at Amazon.com.
-
Lactobacillus plantarum
HNU082 alleviates dextran sulfate sodium-induced ulcerative colitis in mice
through regulating gut microbiome - Food Funct 2022 Sep 16 -
"Probiotics have shown good efficacy in the prevention
of ulcerative colitis (UC), but the specific mechanism remains unclear ... In
conclusion, improving gut microbiota dysbiosis, protecting the intestinal
mucosal barrier, regulating inflammatory and disease pathways, and affecting
neutrophil infiltration are the potential mechanisms of probiotic Lp082 in
alleviating UC. Our study enriches the mechanism and provides a new prospect for
Lactobacillus plantarum HNU082 in the prevention of colitis, provides support
for the development of probiotic-based microbial products as an alternative
prevention strategy for UC, and provides guidance for the future probiotic
prevention of human colitis" - See
probiotic supplements at Amazon.com.
-
Betaine ameliorates acute
sever ulcerative colitis by inhibiting oxidative stress induced inflammatory
pyroptosis - Mol Nutr Food Res 2022 Sep 7 - "Betaine
rich in beet is used as an important source of human nutrition. Here we aimed to
explore whether betaine supplementation can protect against acute sever
ulcerative colitis (ASUC) and the underlying mechanism ... Betaine inhibits
colonic oxidative stress induced inflammatory pyroptosis to alleviate ASUC,
which shows therapeutic potential against colitis and other acute inflammatory
disorder" - See betaine anhydrous (TMG) at Amazon.com
and beet root powder at Amazon.com.
-
Preventive effect of pectic
oligosaccharides on acute colitis model mice: modulating epithelial barrier, gut
microbiota and Treg/Th17 balance - Food Funct 2022 Sep 6 -
"Pectin as a dietary fiber supplement has shown emerging
potential in clinical ulcerative colitis (UC) adjuvant therapy ... pectic
oligosaccharides (POS) ... All of these results suggest that enzymatically-
degraded POS is a promising therapeutic agent for UC prevention and adjuvant
treatment by maintaining intestinal homeostasis" - See
Inulin at Amazon.com.T
-
he role of functional
oligosaccharides as prebiotics in ulcerative colitis - Food Funct 2022 Jul 4
- "The current studies on UC implicate a strong
correlation between host gut microbiota immunity and the pathogenesis of UC.
Meanwhile, more and more functional oligosaccharides have been reported as
prebiotics to alleviate UC, since many of them can be metabolized by gut
microbiota to produce short-chain fatty acids (SCFAs). The present review is
focused on the structure, sources and specific applications of various
functional oligosaccharides related to the prevention and treatment of UC. The
available evidence for the usage of functional oligosaccharides in UC treatment
are summarized, including fructo-oligosaccharides (FOS),
galacto-oligosaccharides (GOS), chito-oligosaccharides (COS),
alginate-oligosaccharides (AOS), xylooligosaccharides (XOS), stachyose and
inulin" - See inulin at Amazon.com.
-
Non-linear Association
between Serum 25-Hydroxyvitamin D and All-cause Mortality in Adults with
Inflammatory Bowel Disease in a Prospective Cohort Study - J Nutr 2022 Jul
11 - "We observed a non-linear association, mostly
applied to the females, between serum 25(OH)D concentrations and all-cause
mortality among individuals with IBD. A concentration range of 44-78 nmol/L of
25(OH)D can serve as a starting point for future research to confirm recommended
25(OH)D concentrations for individuals with IBD" - See
vitamin D at Amazon.com.
-
Manipulation of Gut
Microbiota as a Key Target for Crohn's Disease - Front Med (Lausanne) 2022
Jun 16 - "Other medications often used concomitantly in
IBD, such as antibiotics, antidepressants, oral contraceptives, opioids, and
proton pump inhibitors, have shown to alter the gut microbiota and account for
increased susceptibility to disease onset or worsening of disease progression.
In contrast, some environmental modifications through alternative therapies
including fecal microbiota transplant (FMT), diet and dietary supplements with
prebiotics, probiotics, and synbiotics have shown potential protective effects
by reversing microbiota dysbiosis or by directly promoting beneficial microbes,
together with minimal long-term adverse effects" - See
probiotic supplements at Amazon.com,
prebiotic supplements at
Amazon.com and synbiotic supplements at Amazon.com.
-
The role of functional
oligosaccharides as prebiotics in ulcerative colitis - Food Funct 2022 Jun
15 - "The current studies on UC implicate a strong
correlation between host gut microbiota immunity and the pathogenesis of UC.
Meanwhile, more and more functional oligosaccharides have been reported as
prebiotics to alleviate UC, since many of them can be metabolized by gut
microbiota to produce short-chain fatty acids (SCFAs). The present review is
focused on the structure, sources and specific applications of various
functional oligosaccharides related to the prevention and treatment of UC"
- See inulin at Amazon.com.
-
Dietary soybeans worsen
dextran sodium sulfate-induced colitis by disrupting intestinal ecology -
Food Funct 2022 May 18 - "the intake of soybeans and
soybean carbohydrates is not conducive to recovery from IBDs based on changes in
gut microbiota and metabolites affecting the activities of macrophages."
-
Probiotic Improves
Symptoms of Irritable Bowel Syndrome - Medscape, 5/9/22 -
"After the 30-day treatment period with B longum 35624,
a significant decrease in IBS severity was observed, compared with baseline. The
IBS-SSS score went from 303 to 208 (P < .001). More than half of the patients
(57%) experienced an overall decrease in their symptoms. The rate of severe
symptoms decreased from 46.6% to 20%; moderate symptoms decreased from 48.1% to
36.1%; mild symptoms increased from 4.7% to 35.2%; and 8.7% of patients were in
remission after the treatment vs 0.9% before. A significant improvement in
disease severity (more than a 50-point decrease in the IBS-SSS score) was
observed in 65.7% of patients, regardless of the IBS subtype ... After 30 days
of treatment, a significant improvement in quality of life was noted in the
patients (IBS-QOL score 68.8 vs 60.2, P < .001), and more than 6 out of 10 (63%)
were satisfied with the treatment" - See
probiotic supplements at Amazon.com.
-
EPA and DHA differentially
coordinate the crosstalk between host and gut microbiota and block DSS-induced
colitis in mice by a reinforced colonic mucus barrier - Food Funct 2022 Mar
17 - "Ulcerative colitis (UC) is a chronic inflammatory
disorder of the colon with a continuously remitting and relapsing course. Its
etiology is closely related to abnormal interactions between host and gut
microbiota. The mucus barrier lining the gastrointestinal tract is necessary to
coordinate host and gut microbiota interaction by nourishing and modulating the
microbiota. Differential effects of the anti-inflammatory fatty acids
docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) on UC progression in
mice were firstly addressed by our previous work; here, the mechanism for their
respective effects were further uncovered from host-microbiome crosstalk based
on mucus barrier modulation to pave the way for UC therapy ... EPA and DHA
differentially coordinate the interaction between the host and the gut
microbiota and relieve mucus barrier disruption in DSS-induced colitis. EPA may
develop into a promising adjunctive therapy for UC" - See
omega-3 supplements at Amazon.com.
-
Curcumin regulates the
homeostasis of Th17/Treg and improves the composition of gut microbiota in type
2 diabetic mice with colitis - Phytother Res 2022 Mar 2 -
"Diabetes mellitus (DM) is one of the most common
complications in patients with ulcerative colitis (UC). Curcumin has a wide
range of bioactive and pharmacological properties and is commonly used as an
adjunct to the treatment of UC and DM ... In this study, curcumin (100
mg/kg/day) significantly improved the symptoms of diabetes complicated by UC,
with a lower insulin level, heavier weight, longer and lighter colons, fewer
mucosal ulcers and less inflammatory cell infiltration. Moreover, compared to
untreated DB mice with colitis, curcumin-treated mice showed weaker Th17
responses and stronger Treg responses. In addition, curcumin regulated the
diversity and relative abundance of intestinal microbiota in mice with UC
complicated by DM at the phylum, class, order, family and genus levels.
Collectively, curcumin effectively alleviated colitis in mice with type 2
diabetes mellitus by restoring the homeostasis of Th17/Treg and improving the
composition of the intestinal microbiota" - See
curcumin at Amazon.com.
-
Alpha-ketoglutarate
attenuates colitis in mice by increasing Lactobacillus abundance and regulating
stem cell proliferation via Wnt-Hippo signaling - Mol Nutr Food Res 2022 Feb
26 - "Collectively, the data provided herein
demonstrated that α-KG administration attenuated mucosal inflammation, barrier
dysfunction, and gut microflora dysbiosis. This beneficial effect was associated
with increased Lactobacillus levels and regulated colon hyperplasia by the Wnt-Hippo
signaling pathway" - See alpha ketoglutarate at Amazon.com.
-
Enhanced
co-culture and enrichment of human natural killer cells for the selective
clearance of senescent cells - Aging (Albany NY) 2022 Mar 4 - "In
the context of aging and age-associated diseases, Natural Killer (NK) cells have
been revealed as a key cell type responsible for the immune clearance of
senescent cells. Subsequently, NK cell-based therapies have emerged as promising
alternatives to drug-based therapeutic interventions for the prevention and
treatment of age-related disease and debility. Given the promise of NK
cell-mediated immunotherapies as a safe and effective treatment strategy, we
outline an improved method by which primary NK cells can be efficiently enriched
from human peripheral blood across multiple donors (ages 20-42 years old), with
a practical protocol that reliably enhances both CD56dim and CD56bright NK cells
by 15-fold and 3-fold, respectively. Importantly, we show that our co-culture
protocol can be used as an easily adaptable tool to assess highly efficient and
selective killing of senescent cells by primary NK cells enriched via our method
using longer co-culture durations and a low target to effector ratio, which may
be more physiological than has been achieved in previous literature"
-
Phycocyanin - Wikipedia -
"Phycocyanin is a pigment-protein complex from the
light-harvesting phycobiliprotein family, along with
allophycocyanin and phycoerythrin.[1] It is an accessory
pigment to chlorophyll. All phycobiliproteins are
water-soluble, so they cannot exist within the membrane like
carotenoids can"
-
Curcumin Mitigates
TNFα-Induced Caco-2 Cell Monolayer Permeabilization Through modulation of NF-κB,
ERK1/2 and JNK Pathways - Mol Nutr Food Res 2022 Feb 19 -
"The inhibition of NF-κB, ERK1/2 and JNK activation
could be in part involved in the capacity of curcumin to mitigate intestinal
inflammation, oxidant production, activation of redox-sensitive pathways, and
prevention of monolayer permeabilization. These results support an action of
dietary curcumin in sustaining gastrointestinal tract physiology" -
See
curcumin at Amazon.com.
-
Curcumin Alleviates Dextran
Sulfate Sodium-induced Colitis in Mice Through Regulating Gut Microbiota -
Mol Nutr Food Res 2022 Feb 2 - "Curcumin is a natural
polyphenol compound with multiple pharmacologic activities. The present study
aims to explore the potential therapeutic properties of curcumin on intestinal
inflammatory diseases, including its anti-inflammatory, anti-oxidant, and
anti-apoptotic properties, as well as their associations with altered intestinal
microbiome ... curcumin shows therapeutic potential against colitis. It may be
served as alternative medicine or adjuvant therapy in the treatment of colitis"
- See curcumin at Amazon.com.
-
Metformin
ameliorates chronic colitis in a mouse model by regulating
interferon-γ-producing lamina propria CD4 + T cells through AMPK
activation - FASEB J 2022 Feb -
"Metformin, a commonly prescribed drug for type 2 diabetes
mellitus, has been shown to activate AMP-activated protein
kinase (AMPK). Notably, AMPK activation has recently been
observed to be associated with anti-inflammatory responses.
Metformin is also reported to elicit anti-inflammatory responses
in CD4+ T cells, resulting in improvement in experimental
chronic inflammatory diseases, such as systemic lupus
erythematosus ... metformin suppresses the frequency of
interferon (IFN) -γ-producing LP CD4+ T cells in vitro, which
were regulated by AMPK activation, a process possibly induced by
the inhibition of oxidative phosphorylation. Furthermore, we
examined the effects of metformin on an in vivo IBD model.
Metformin-treated mice showed AMPK activation in LP CD4+ T cells
and ameliorated colitis. Our study demonstrates that
metformin-induced AMPK activation in mucosal CD4+ T cells
contributes to the improvement of IBD by suppressing IFN-γ
production. Moreover, our results indicate that AMPK may be a
target molecule for the regulation of mucosal immunity and
inflammation. Thus, AMPK-activating drugs such as metformin may
be potential therapeutic agents for the treatment of IBD"
- See
metformin at ReliableRX.
-
Orange
Pectin with Compact Conformation Effectively Alleviates Acute
Colitis in Mice - J Agric Food Chem 2022 Jan 26 -
"In this study, we compared the
alleviating effects of five orange pectins (200 mg/kg) extracted
using acid (P2), alkali (P10), cellulase (C), acid + cellulase
(P2 + C), and alkali + cellulase (P10 + C) on dextran sodium
sulfate-induced acute colitis. The physiological and
histopathological indicators revealed that the alleviating
effects were most significant for P10 + C, followed by P10, P2 +
C, P2, and C. P10 + C increased the diversity and relative
abundance of Akkermansia, leading to increased generation of
colonic short-chain fatty acids as well as mRNA and protein
expressions of GPR43, GPR109A, claudin-1, ZO-1, and occludin.
Therefore, proinflammatory cytokines were decreased, and
anti-inflammatory cytokines were increased. A compact
conformation of P10 + C contributed to the alleviation effects
on acute colitis. Alkali + cellulase-extracted orange pectin
with a compact conformation has potential as adjuvant treatment
for intestinal inflammation" - See
Akkermansia at Amazon.com and
pectin supplements at Amazon.com.
-
Pomegranate Extract Improves
Colitis in IL-10 Knockout Mice fed a High Fat High Sucrose Diet - Mol Nutr
Food Res 2021 Dec 21 - "Our data demonstrated that
dietary PomX supplementation ameliorated colitis and lowered inflammatory
markers in HFHS fed IL10-/- mice. These data support the anti-inflammatory
effects of dietary PomX supplementation for IBD and a potential mediating role
of gut microbiome, suggesting the need for future clinical studies to explore
the use of PomX dietary supplementation in IBD patients" - See
pomegranate extract at
Amazon.com.
-
Protective Effect of
l-Theanine against DSS-Induced Colitis by Regulating the Lipid Metabolism and
Reducing Inflammation via the NF-κB Signaling Pathway - J Agric Food Chem
2021 Nov 16 - "In summary, l-theanine plays a protective
role in DSS-induced colitis via downregulating the NF-κB signaling pathway and
regulating lipid metabolism disorders" - See
L-theanine at Amazon.com.
-
St. John's Wort alleviates
dextran sodium sulfate-induced colitis through pregnane X receptor-dependent
NFκB antagonism - FASEB J 2021 Nov - "St. John's
wort (SJW), from traditional herbs, activates the pregnane X receptor (PXR), a
potential drug target for treating inflammatory bowel disease (IBD) ... These
data indicate the therapeutic potential of SJW in alleviating DSS-induced IBD in
vivo, and TNFα-induced NFκB activation in vitro, dependent on PXR activation,
which may have clinical implications for using SJW as a herbal drug anti-IBD"
- See
St. John's wort at Amazon.com.
-
Curcumin Alleviated Dextran
Sulfate Sodium-Induced Colitis by Regulating M1/M2 Macrophage Polarization and
TLRs Signaling Pathway - Evid Based Complement Alternat Med 2021 Sep 16 -
"Curcumin has shown good efficacy in mice with
experimental colitis and in patients with ulcerative colitis, but the mechanism
of action through the regulation of M1/M2 macrophage polarization has not been
elaborated ... Our study suggested that curcumin exerted therapeutic effects in
colitis mice by regulating the balance of M1/M2 macrophage polarization and TLRs
signaling pathway" - See curcumin at Amazon.com and
iHerb.
-
Lactobacillus johnsonii
Attenuates Citrobacter rodentium-Induced Colitis by Regulating Inflammatory
Responses and Endoplasmic Reticulum Stress in Mice - J Nutr 2021 Aug 12 -
"Probiotics are beneficial in intestinal disorders.
However, the benefits of Lactobacillus johnsonii in experimental colitis remain
unknown ... L. johnsonii supplementation is a promising nutritional strategy for
preventing C. rodentium-induced colitis in mice" - See
Lactobacillus johnsonii at Amazon.com.
-
Pectins that Structurally
Differ in the Distribution of Methyl-esters Attenuate Citrobacter rodentium-Induced
Colitis - Mol Nutr Food Res 2021 Aug 9 - "Pectins
have anti-inflammatory properties on intestinal immunity through direct
interactions on Toll-like receptors (TLRs) in the small intestine or via
stimulating microbiota-dependent effects in the large intestine. Both the degree
of methyl-esterification (DM) and the distribution of methyl-esters (degree of
blockiness; DB) of pectins contribute to this influence on immunity but whether
and how the DB impacts immunity through microbiota-dependent effects in the
large intestine is unknown ... Pectins prevent C. rodentium-induced colonic
inflammation by lowering the C. rodentium load in the caecum independently of
the DB" - See
pectin supplements at Amazon.com.
-
Effects of olives and their
constituents on the expression of ulcerative colitis: a systematic review of
randomized controlled trials - Br J Nutr 2021 Jun 8 -
"Extra virgin olive oil (EVOO) is often associated with
anti-inflammatory and antioxidant properties. Its effects on inflammatory
conditions such as Ulcerative Colitis (UC) however has yet to be defined ...
Milder disease expression including weight maintenance, reduced rectal bleeding
and well-formed stools favouring olive-based interventions was statistically
significant in 16/19 studies, with moderate-to-large effect sizes (ESs -0.66
(95% CI -1.56, 0.24) to -12.70 (95% CI -16.8, -8.7)). Olive-based interventions
did not prevent the development of colitis-like pathologies in any study. In
conclusion, effects of olive-based interventions on murine models of UC appear
promising, with milder disease outcomes favouring the intervention in most
trials and effect sizes suggesting potential clinical relevance. However, the
lack of published randomized controlled human trials warrants further
investigation to determine if these effects would translate to individuals
living with UC" - See
olive leaf extract at Amazon.com.
-
Efficacy of a curcumin extract (Curcugen™) on gastrointestinal symptoms and
intestinal microbiota in adults with self-reported digestive complaints: a
randomised, double-blind, placebo-controlled study - BMC Complement Med Ther
2021 Jan 21 - "There is preliminary evidence to suggest
curcumin can alleviate digestive symptoms in adults with self-reported digestive
complaints and irritable bowel syndrome ... 79 adults with self-reported
digestive complaints were recruited and randomised to receive either a placebo
or 500 mg of the curcumin extract, Curcugen™ ... The curcumin extract, Curcugen™,
administered for 8 weeks at a dose of 500 mg once daily was associated with
greater improvements in digestive complaints and anxiety levels in adults with
self-reported digestive complaints" - [Nutra
USA] - See curcumin at Amazon.com.
-
Supplemental Choline
Modulates Growth Performance and Gut Inflammation by Altering the Gut Microbiota
and Lipid Metabolism in Weaned Piglets - J Nutr 2020 Nov 26 -
"Choline supplementation improved growth performance and
prevented gut inflammation in weaned piglets by altering gut microbiota and
lipid metabolism" - See citicholine at Amazon.com and
iHerb.
-
Chlorogenic Acid Suppresses
miR-155 and Ameliorates Ulcerative Colitis Through the NF-κB/NLRP3 inflammasome
Pathway - Mol Nutr Food Res 2020 Oct 20 - "These
findings indicate that CGA prevented colitis by downregulating miR-155
expression and inactivating the NF-κB/NLRP3 inflammasome pathway in macrophages.
The current study may have promising therapeutic implications in the treatment
of ulcerative colitis" - See chlorogenic acid at
Amazon.com and
iHerb.
-
Effects of saffron
supplementation on oxidative/antioxidant status and severity of disease in
ulcerative colitis patients: A randomized, double-blind, placebo-controlled
study - Phytother Res 2020 Oct 4 - "Supplementation
with saffron helps improve antioxidant status. Oxidative stress plays an
important role in ulcerative colitis (UC) ... Participants were randomly divided
into intervention (100 mg saffron/daily) and placebo (100 mg maltodextrin/daily)
groups. Of all the participants, 75 completed the study. After 8 weeks, there
were significantly increased in the mean score of simple clinical colitis
activity index questionnaire (3.83 ± 1.78 to 3 ± 1.60, p = .004), the serum
levels of total antioxidant capacity (2.68 ± 0.90 to 2.79 ± 0.87, p = .016),
superoxide dismutase (60.69 ± 9.59 to 66.30 ± 10.79, p = .009) and glutathione
peroxidase (22.05 ± 14.27 to 29.67 ± 17.97, p = .011) in patients received
saffron compared to the placebo group ... dietary saffron as an alternative
therapy may effective in improving antioxidant factors and reducing the severity
of disease in UC patients" - See saffron supplements at Amazon.com.
-
Berry
good news: newly discovered compound from blueberries could treat inflammatory
disorders - Science Daily, 9/23/20 - "In their
latest study, published in The FASEB Journal, the scientists identified a
polyphenolic compound called "pterostilbene" (PSB) with strong immunosuppressive
properties -- making it a potential therapeutic option for chronic inflammatory
diseases, including inflammatory bowel disease (IBD). This compound is very
similar to another phytocompound known to have important medicinal effects,
called "resveratrol" (RSV) ... Our findings showed that PSB possesses a strong
immunosuppressive property, paving the way for a new, natural treatment for IBD"
- See pterostilbene at Amazon.com and
iHerb.
-
Vitamin D Tied to Lower
Risk for Immunotherapy-Induced Colitis - Medscape, 7/2/20 -
"Taking vitamin D before starting immune checkpoint
inhibitor (ICI) therapy may decrease the risk for treatment-related colitis ...
Results from animal studies suggest that vitamin D may modulate the immune
system and protect against inflammatory bowel diseases such as ulcerative
colitis and Crohn disease. ICI colitis shows similarities with inflammatory
bowel disease, which may account for why vitamin D may be protective against ICI
colitis ... Vitamin D use was linked to 65% decreased odds of developing ICI
colitis (odds ratio [OR], 0.35; 95% confidence interval [CI], 0.1 – 0.9; P =
.01) ... For the confirmatory cohort of patients from Massachusetts General,
results were similar: 29% (49/169) developed ICI colitis, and vitamin D intake
was tied to 54% decreased odds of colitis" - See
vitamin D at Amazon.com and
vitamin D
at iHerb.
-
Vitamin
D may help prevent a common side effect of anti-cancer immunotherapy -
Science Daily, 6/22/20 - "The study included
information on 213 patients with melanoma who received immune checkpoint
inhibitors between 2011 and 2017. Thirty-seven (17 percent) of these patients
developed colitis. Sixty-six patients in the study (31 percent) took vitamin D
supplements before starting treatment with immune checkpoint inhibitors ...
Patients who took vitamin D had 65 percent lower odds of developing colitis"
- See vitamin D at Amazon.com and
vitamin D
at iHerb.
-
Walnut Oil Alleviates
Intestinal Inflammation and Restores Intestinal Barrier Function in Mice -
Nutrients. 2020 May 2 - "Ulcerative colitis belongs to
inflammatory bowel diseases, which is a group of chronic disorders of the
gastrointestinal tract. It is a debilitating condition with a wide range of
symptoms including rectal bleeding, diarrhea, and visceral pain. Current dietary
habits often lead to imbalance in n-6/n-3 polyunsaturated fatty acids (PUFA) in
favor of n-6 PUFA. Recent data showed the potential anti-inflammatory advantage
of n-3 PUFA. Walnut oil (WO) is rich in those fatty acids and mainly consists of
linoleic and linolenic acids that may act via free fatty acids receptors
(FFARs). We assessed the anti-inflammatory effect of WO in the mouse model of
dextran sulfate sodium (DSS)-induced colitis. Moreover, we examined changes in
the expression of tight junction proteins (TJ), pro-inflammatory cytokines, and
FFAR proteins in the inflamed mouse colon. WO improves the damage score in
inflamed tissue, significantly restoring ion transport and colonic wall
permeability. Inflammation caused changes in TJ, FFAR, and pro-inflammatory gene
proteins expression, which WO was able to partially reverse. WO has
anti-inflammatory properties; however, its exact mechanism of action remains
unclear. This stems from the pleiotropic effects of n-3 PUFA ligands associated
with receptor distribution and targeted signaling pathways" - See
walnut oil at Amazon.com and
walnut oil at iHerb.
-
Certain
foods common in diets of US adults with inflammatory bowel disease - Science
Daily, 5/6/20 - "Foods, such as French fries, cheese,
cookies, soda, and sports and energy drinks, are commonly found in the diets of
United States adults with inflammatory bowel disease"
-
Lactobacillus acidophilus
DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and
Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial -
Nutrients. 2020 Jan 30 - "The primary outcome was the
change in Abdominal Pain Severity - Numeric Rating Scale (APS-NRS). Over the
intervention period, APS-NRS was significantly improved in both probiotic groups
vs. placebo in absolute terms (DDS-1: -2.59 ± 2.07, p = 0.001; UABla-12: -1.56 ±
1.83, p = 0.001) and in percentage of significant responders (DDS-1: 52.3%, p <
0.001); UABla-12 (28.2%, p = 0.031). Significant amelioration vs. placebo was
observed in IBS Symptom Severity Scale (IBS-SSS) scores for L. acidophilus DDS-1
(-133.4 ± 95.19, p < 0.001) and B. lactis UABla-12 (-104.5 ± 96.08, p < 0.001)
groups, including sub-scores related to abdominal pain, abdominal distension,
bowel habits and quality of life. Additionally, a significant normalization was
observed in stool consistency in both probiotic groups over time and as compared
to placebo. In conclusion, L. acidophilus DDS-1 and B. lactis UABla-12 improved
abdominal pain and symptom severity scores with a corresponding normalization of
bowel habits in adults with IBS" - [Nutra
USA] - See probiotic supplements at
Amazon.com
and
probiotic supplements at iHerb.
-
A Phase I Trial of
Berberine in Chinese with Ulcerative Colitis - Cancer Prev Res (Phila). 2019
Oct 16 - "The Chinese natural product, berberine, has biological properties
supporting potential efficacy as a colon cancer prevention agent. Its
longstanding use in China to treat gastrointestinal tract and rheumatologic
disorders is generally regarded as safe, supporting initial investigations in an
at-risk population, such as individuals with ulcerative colitis (UC). However,
the safety of berberine in this population is not established. Individuals
living in China with biopsy-proven UC, ≤ grade 2 dysplasia, and with a UC
disease activity index (UCDAI) score ≤ 1 on mesalamine, were randomized 3:1 in a
double-blind phase I trial to berberine 900 mg/day or placebo for 3 months, with
the primary objective of assessing safety ... The combination of berberine and
mesalamine is well tolerated in Chinese with UC, and may enhance mesalamine's
anti-inflammatory effects in colonic tissue" - See
berberine at Amazon.com.
-
The
diet-microbiome connection in inflammatory bowel disease - Science Daily,
9/9/19 - "The bacteria in the gut are known to be a
really important factor in tipping the scales toward disease ... And the
environmental factor that seems to contribute the most to rapid changes in the
microbiome is what you eat. Given that dogs' microbiomes are extremely similar
to those of humans, we thought this was an intriguing model to ask, 'Could diet
be impacting this disease through an impact on the microbiome?'" ... One of
these "good" microbes that can give rise to secondary bile acids was the
bacterium Clostridium hiranonis, which the researchers found in greater numbers
in dogs that went into remission ... Youngsters who responded to the therapy had
an increase in numbers of the bacteria species Clostridium scindens, which, like
C. hiranonis, is a potent producer of secondary bile acids" - See
probiotic products at Amazon.com.
-
Hesperidin Protects
Against Intestinal Inflammation By Restoring Intestinal Barrier Function and Up
Regulating Treg Cells - Mol Nutr Food Res. 2019 Feb 28 -
"Hesperidin
supplementation ameliorated DSS-induced colitis. Specifically, hesperidin
ameliorates intestine inflammation through decreasing MDA activity and enhancing
SOD and GSH activities. Hesperidin also obviously upregulation Nrf2 antioxidant
pathway and increased the protein expression of HO-1 and NQO1. Additionally,
hesperidin significantly reduced the levels of inflammatory factors and
increased the levels of anti-inflammatory factors in the colon tissues. Further
analysis showed that hesperidin could improve the expression of tight junction
proteins and intestinal permeability, as well as increased the Treg population.
In Caco-2 cells, we showed that hesperidin prevented TNF-α/IFN-γ-induced reduced
in TEER and morphological disruption. Moreover, hesperidin also was shows
decreased the epithelial permeability and suppress proinflammatory responses" -
See
hesperidin at Amazon.com.
-
The Efficacy of
Prebiotics, Probiotics, Synbiotics and Antibiotics in Irritable Bowel Syndrome
- Medscape, 11/22/18 - "The search identified 4017
citations. Data for prebiotics and synbiotics were sparse. Fifty-three RCTs of
probiotics, involving 5545 patients, were eligible. Particular combinations of
probiotics, or specific species and strains, appeared to have beneficial effects
on global IBS symptoms and abdominal pain, but it was not possible to draw
definitive conclusions about their efficacy. There were five trials of similar
design that used rifaximin in non-constipated IBS patients, which was more
effective than placebo (RR of symptoms persisting = 0.84; 95% CI 0.79–0.90).
Adverse events were no more common with probiotics or antibiotics" - See
probiotic products at Amazon.com.
-
Probiotics, Fecal
Transplant Promising in Ulcerative Colitis - Medscape, 10/15/18 -
"the researchers reviewed 16 relevant randomized
controlled trials that used markedly different protocols ... Overall, probiotics
were effective for clinical remission and clinical response in ulcerative
colitis. And when we divided it to see which probiotic actually was effective,
FMT was number one and VSL#3 was number two" - See
probiotic products at Amazon.com.
-
Strawberries could help reduce harmful inflammation in the colon - Science
Daily, 8/20/18 - "The sedentary lifestyle and dietary
habits of many people in this country -- high-sugar, high-animal-fat, but
low-fiber diets -- may promote colonic inflammation and increase the risk of IBD
... The researchers found that dietary consumption of whole strawberries at a
dose equivalent to as low as three-quarters of a cup of strawberries per day in
humans significantly suppressed symptoms like body weight loss and bloody
diarrhea in mice with IBD. Strawberry treatments also diminished inflammatory
responses in the mice's colonic tissue ... But decreased inflammation wasn't the
strawberry's only conferred benefit during this study. Colonic inflammation
adversely impacts the composition of microbiota in the gut. With IBD, the
abundance of harmful bacteria increases, while levels of beneficial bacteria
decrease in the colon. Following the dietary treatments of whole strawberries,
the researchers observed a reversal of that unhealthy microbiota composition in
the IBD mice"
-
New
research on probiotics in the prevention and treatment of colon cancer -
Science Daily, 9/13/17 - "These results suggest that
alteration of the gut microbiome with probiotics may become a new preventative
or therapeutic strategy for patients at risk for inflammatory bowel disease
(IBD)-associated CRC ... The active probiotic also reduced inflammation induced
by the carcinogen plus DSS, as indicated by suppressed pro-inflammatory cytokine
gene expression (i.e., those encoding KC, interleukin (IL)-22, IL-6, tumor
necrosis factor (TNF), and IL-1?) and reduced cytokine concentrations in plasma
(i.e., KC, IL-22, and IL-6). The active probiotic also counteracted an increase
in immature myeloid cells induced by the carcinogen" - See
probiotic products at Amazon.com.
-
Lycopene Ameliorates
Experimental Colitis in Rats via Reducing Apoptosis and Oxidative Stress -
Int J Vitam Nutr Res. 2017 Jul 19:1-9 - "The results
obtained in this study indicate that lycopene may exert protective effects in
experimental colitis and might, therefore, be useful for treatment of IBD"
- See
lycopene at Amazon.com.
-
Vinegar
treatment prevents the development of murine experimental colitis via inhibition
of inflammation and apoptosis - J Agric Food Chem. 2016 Jan 21 -
"This study investigated the preventive effects of
vinegar and acetic acid (the active component of
vinegar) on ulcerative colitis (UC) in mice. Vinegar (5% v/v) or acetic acid
(0.3% w/v) treatment significantly reduced the disease activity index and
histopathological scores, attenuated body weight loss and shortened the colon
length in a murine experimental colitis model induced by dextran sulfate sodium
(DSS) ... Surprisingly, pretreatment with vinegar for 28 days before DSS
induction increased levels of the commensal lactic acid-producing or acetic
acid-producing bacteria, including Lactobacillus, Bifidobacteria and
Enterococcus faecalis, whereas decreased Escherichia coli levels were found in
the feces of mice. These results suggest that vinegar supplement might provide a
new dietary strategy for the prevention of UC" - See
apple cider vinegar at Amazon.com.
-
Vitamin
D shows promise for treating Crohn's disease - Science Daily, 6/12/15 -
"the authors assigned 27 CD patients in remission to
2000 IU/day vitamin D supplementation or placebo for 3 months. They found, that
patients treated with the supplementation were more likely to maintain their
intestinal permeability, whereas this deteriorated in the placebo group.
Increased intestinal permeability is considered a measure of gut leakiness,
which is shown to predict and precede clinical relapse in CD. In addition,
patients with the highest blood levels of vitamin D had signs of reduced
inflammation (measured by C-reactive protein and antimicrobial peptides), and
these patients also reported better quality of life" - See
vitamin D at Amazon.com.
-
Boswellia
serrata has Beneficial Anti-Inflammatory and Antioxidant Properties in a Model
of Experimental Colitis - Phytother Res. 2014 Mar 12 -
"Boswellia serrata plant ... The B. serrata extract has
protective anti-inflammatory and antioxidant effects that inhibit inflammatory
mediators in acute experimental colitis" - See
Boswellia at Amazon.com.
-
Panax
notoginseng Attenuates Experimental Colitis in the Azoxymethane/Dextran Sulfate
Sodium Mouse Model - Phytother Res. 2013 Oct 21 -
"Our data suggest that P. notoginseng is a promising candidate in preventing and
treating colitis and inflammation-associated colon carcinogenesis" - See
ginseng at Amazon.com.
- Panax
pseudoginseng - Wikipedia, the free encyclopedia -
"Panax notoginseng is a species of the genus Panax"
-
Extra Vitamin D May Ease Crohn's Symptoms, Study Finds - WebMD, 5/20/13 -
"Extra vitamin D "was associated with significantly less
physical, emotional and general fatigue, greater quality of life and the ability
to perform activities of daily living," ... evaluated 27 patients who had
Crohn's in remission. (Even in remission, fatigue and quality of life can be
problematic.) The patients were assigned to take either 2,000 IUs (international
units) of vitamin D a day or a dummy vitamin for three months" - See
vitamin D at Amazon.com.
-
The
anti-inflammatory potential of phenolic compounds in grape juice concentrate
(G8000™) on 2,4,6-trinitrobenzene sulphonic acid-induced colitis - Br J
Nutr. 2013 Mar 22:1-8 - "Chronic inflammatory bowel
disease is characterised by an up-regulation of the synthesis and release of a
variety of pro-inflammatory mediators leading to excessive tissue injury.
Flavonoids are able to inhibit enzymes and/or due to their antioxidant
properties regulate the immune response. The goal of the present study was to
evaluate the mechanisms of action of phenolic compounds present in grape juice
on 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis. A total of
forty-one male Wistar rats were randomised into seven groups: negative control
group; TNBS non-treated induced colitis; 2 % grape juice control group; 1 %
grape juice 24 h after TNBS colitis induction; 1 % grape juice on day 7 after
colitis induction; 2 % grape juice 24 h after colitis induction; 2 % grape juice
on day 7 after colitis induction. The 1 % grape juice-treated induced colitis
group showed marked clinical improvement when compared with the TNBS-induced
colitis group" - See Jarrow Formulas, OPCs + 95 at Amazon.com
or
Garden of Life, Radical Fruits Antioxidant Complex at Amazon.com.
-
The
importance of vitamins D and K for the bone health and immune function in
inflammatory bowel disease - Curr Opin Clin Nutr Metab Care. 2012 Aug 20 -
"The levels of vitamins D and K are lower than normal in
patients with IBD, especially in Crohn's disease. Although vitamins D and K are
important for the maintenance of bone mineral density in non-IBD patients, an
association between vitamins D or K and bone metabolism is not apparent in IBD
patients. Recent studies showed that vitamins D and K are suggested to have
immune-suppressive effects, both in animal models of colitis and human trials.
In particular, vitamin D suppresses dendritic and T-cell functions by inhibiting
the production of proinflammatory cytokines. Insufficiency of vitamin D is
associated with the activated phenotype of IBD ... Vitamins D and K potentially
contribute to the maintenance of bone health in IBD, but this effect may be
diminished by other factors such as steroid use, reduced exposure to sunlight,
and inflammatory cytokines. Vitamin D and possibly vitamin K are suggested to be
involved in the suppression of immune-mediated inflammation and modulation of
disease activity"
-
Vitamin D and
Inflammatory Bowel Disease - Medscape, 8/9/12 -
"Current understanding points to beneficial effects of vitamin D supplementation
in patients with IBD in terms of bone and muscle preservation, reduction in
inflammation and potentially reduced risk of cancer in patients with IBD.
However, these beneficial effects must be balanced with potential adverse
effects in the clinical setting. The precise thresholds of serum 25(OH) vitamin
D for beneficial and potentially adverse effects remain poorly defined in the
literature. Until further evidence is available, we recommend to aim for a serum
25(OH) vitamin D level of 75 nmol/L. In a condition with a propensity to affect
young people and a disproportionate effect on quality of life and productivity,
the potential advent of inexpensive supplementary therapies presents an
attractive option for ongoing research" - See
vitamin D at Amazon.com.
-
Invisible helpers: How probiotic bacteria protect against inflammatory bowel
diseases - Science Daily, 4/26/12 - "In experiments
with mice, the scientists observed that lactocepin -- an enzyme produced from
the lactic acid bacterium Lactobacillus paracasei -- can selectively interrupt
inflammatory processes. As the scientists observed, lactocepin degrades
messengers from the immune system, known as chemokines, in the diseased tissue.
As a part of the "normal" immune response, chemokines are needed to guide
defense cells to the source of the infection. In chronic intestinal disorders
like Crohn's disease and ulcerative colitis, the otherwise highly effective
defense mechanism against infectious agents is malfunctioning. Chemokines such
as "IP-10" then contribute to the tissue damage due to chronic inflammatory
processes, preventing the tissue from healing" - See
probiotics at Amazon.com.
-
Conjugated
linoleic acid modulates immune responses in patients with mild to moderately
active Crohn's disease - Clin Nutr. 2012 Apr 19 -
"Thirteen patients with mild to moderately active CD were enrolled in an
open-label study of CLA (6 g/d orally) for 12 weeks ... CD activity index (CDAI)
... Inflammatory Bowel Disease Questionnaire (IBDQ) ... CLA significantly
suppressed the ability of peripheral blood CD4+ and CD8+ T cell subsets to
produce IFN-γ, TNF-α and IL-17 and lymphoproliferation at week 12. There was a
statistically significant drop in CDAI from 245 to 187 (P = 0.013) and increase
in IBDQ from 141 to 165 (P = 0.017) on week 12" - See
conjugated linoleic acid at Amazon.com.
-
Vitamin D May Decrease Risk
for Crohn's Disease - Medscape, 3/1/12 - "An
analysis of the data based on predefined plasma 25(OH)D levels showed that
vitamin D–sufficient women (levels ≥ 30 ng/mL) were 62% less likely to be
diagnosed with CD during the 22-year interval than those with deficient vitamin
D levels (<20 ng/mL; hazard ratio [HR], 0.38; 95% confidence interval [CI], 0.15
- 0.97; Ptrend = .048)" - See
vitamin D at Amazon.com.
-
Vitamin D
Status and Cytokine Levels in Patients with Crohns Disease - Int J Vitam
Nutr Res. 2011 Jul;81(4):205-10 - "Results: IL-10 levels
were significantly lower in patients with vitamin D insufficiency compared with
the vitamin D replete group (mean and SE 2.48 +/- 0.51 v 6.77 +/- 2.49 pg/mL, p
< 0.001). There were, however, no differences in serum TNF-alpha or CRP levels
based on vitamin D status. The use of a vitamin D supplement at a low dose (200
IU) did not significantly influence IL-10 levels. Conclusion: Circulating levels
of IL-10, but not TNF-alpha, were significantly lower in CD patients with
inadequate serum 25(OH)D. This suggests that poor vitamin D status may be linked
to reduced anti-inflammatory capacity in this group" - See
vitamin D at Amazon.com.
-
Bilberries may reduce bowel inflammation, boost gut health - Nutra USA,
11/9/11
-
Olive extract shows benefits for inflammatory bowel disease - Nutra USA,
9/12/11 - "Olive oil and the hydroxytyrosol it contains
may reduce inflammation linked with the development of colitis ...
Hydroxytyrosol is thought to be the main antioxidant compound in olives, and
believed to play a significant role in the many health benefits attributed to
olive oil. Previous research has linked the compound to cardiovascular benefits,
with reductions in LDL or 'bad' cholesterol. Data has also suggested the
compound may boost eye health and reduce the risk of against macular
degeneration ... the olive oil-fed animals had an attenuation of the colonic
damage, as well as a 50% reduction in the mortality rate caused by DSS. The
results were improved further by hydroxytyrosol supplement ... levels of the
pro-inflammatory compound interleuking-10 (IL-10) were “significantly improved”
in both olive oil-fed groups" - [Abstract]
- See
olive leaf extract at Amazon.com.
-
Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated
fatty acids in intestinal microvascular endothelium - Clin Nutr. 2011 May 30
- "DHA led to a decreased VCAM-1, TLR4, cyclooxygenase-2
and VEGFR2 expression and a decreased production of IL-6, IL-8 and GM-CSF and a
reduced production of PGE(2) and LTB(4) (p < 0.001) in IL-1β-induced HIMEC.
Similarly, dietary intervention with fish oil rich in EPA and DHA significantly
decreased colon production of PGE(2) and LTB(4,) endothelial VCAM-1 and VEGFR2
in rats with colitis ... Data obtained from in vitro and in vivo studies reveal
a potential anti-angiogenic role of long chain n-3 PUFA in intestinal
endothelial cells. This protective effect of long chain n-3 PUFA may partly
explain the observed benefit of dietary intake of long chain n-3 PUFA in IBD
development" - See
Mega Twin EPA at Amazon.com
and
Jarrow Max DHA at Amazon.com.
-
Comfort
food: Protein from probiotic bacteria may alleviate inflammatory bowel disorders
- Science Daily, 5/23/11 - "A protein isolated from
beneficial bacteria found in yogurt and dairy products could offer a new, oral
therapeutic option for inflammatory bowel disorders (IBD) ... the protein
supports intestinal epithelial cell growth and function, and reduces
inflammatory responses that can cause intestinal cells to die. Importantly, the
investigators showed that oral consumption of p40 by mice in a protective
delivery system prevents and treats colitis in multiple models of the disease
... Many of the hundreds of bacterial species that live in our gut (known as the
"human microbiome") are helpful to us: they help us digest certain substances,
produce vitamins and fight off more dangerous bacteria. But miscommunication
between these bacteria and our gut lining can lead to conditions like ulcerative
colitis and Crohn's disease" - See
probiotics at Amazon.com.
-
Prophylactic
Application of Bovine Colostrum Ameliorates Murine Colitis via Induction of
Immunoregulatory Cells - J Nutr. 2011 Apr 27 - "Herein,
we addressed the question whether bovine colostrum, the first milk produced by
mammals, is able to prevent dextran sulfate sodium (DSS)-induced colitis in mice
... Following 2 wk of observation, the colons were removed for histologic and
immunohistochemical evaluation of inflammation. Flow cytometric phenotyping of
leukocyte subsets was performed from peripheral blood, mesenteric lymph nodes,
and spleens. Administration of bovine colostrum improved the clinical and
histologic severity of colorectal inflammation. Compared with BSA-fed and
water-fed controls, BV-20 pretreated mice had significantly less severe weight
loss and decreased colon shortening. Beneficial effects were accompanied by
redistribution of immunoregulatory, peripheral and splenic γδ TCR(+) cells, and
CD11b(+)Gr1(+) cells. Higher colostrum doses did not affect disease activity. In
summary, prophylactic administration of colostrum improved clinical symptoms of
colorectal inflammation in a well-established mouse model of DSS-induced
colitis" - See
colostrum at Amazon.com.
-
New
probiotic combats inflammatory bowel disease - Science Daily, 1/31/11 -
"Northwestern Medicine researchers deleted a gene in
the probiotic Lactobacillus acidophilus and fed the new form to mice with
two different models of colitis. After 13 days of treatment, the novel
probiotic strain nearly eliminated colon inflammation in the mice and halted
progression of their disease by 95 percent ... In the study, the modified
Lactobacillus acidophilus entered the gut, which is akin to a battlefield of
friendly fire with immune cells attacking the intestine. The Lactobacillus
acidophilus acted as the gut's peacekeeping force, calming the
overstimulated immune cells ... The probiotic restored intestinal peace by
mobilizing messenger immune cells, called dendritic cells. The dendritic
cells, in turn, enhanced the production of other functional immune cells,
regulatory T-cells that rebalanced intestinal and systemic inflammation"
-
Vitamin D absorption is diminished in patients with Crohn's disease,
researchers find - Science Daily, 1/18/11 - "CD
patients had on average a 30 percent decrease in their ability to absorb
vitamin D2 when compared to normal subjects"
-
Cheese whey may protect against IBD: Study - Nutra USA, 12/9/10
-
Vitamin d deficiency puts inflammatory bowel disease patients at greater
risk of osteoporosis, study finds - Science Daily, 10/18/10 -
"IBD patients with an abnormal bone density exam had
a significantly higher rate of Vitamin D deficiency than those who had
normal DEXA scans .... This finding is not surprising since Crohn's disease
usually affects the small intestine, which is the part of the gut that
absorbs the most nutrients" - See
vitamin D at Amazon.com.
-
Dietary
Pectin Regulates the Levels of Inflammatory Cytokines and Immunoglobulins in
Interleukin-10 Knockout Mice - J Agric Food Chem. 2010 Oct 14 -
"Pectin has protective, anti-inflammatory effects on
inflammatory bowel disease (IBD), but the exact mechanism is unknown ... Pectin
treatment reduced expression of TNF-α and GATA-3, an important transcription
factor for the Th2 immune response. These mice also expressed lower levels of
IgE in the spleen and Peyer's patches (PP) and lower IgG and IgM expression in
PP. Interestingly, IL-10 deficiency resulted in lower CD4(+) and CD8(+)
populations in the spleen, mesenteric lymph node (MLN), and PP; however, pectin
counteracted these declines in the MLN and PP. Therefore, dietary pectin
downregulates the inflammatory response in the colon by moderating the
production of proinflammatory cytokines and immunoglobulins" - See
pectin supplements at Amazon.com.
-
Plant extract may be effective against inflammatory bowel disease -
Science Daily, 7/7/10 - "PEITC is found in the
Brassica genus of plants, which includes cabbage, cauliflower, watercress
and broccoli ... it not only alleviates several clinical signs of ulcerative
colitis -- for example, it attenuates the damage that occurs in the colon
tissues and colon epithelium, as well as the clinical signs like diarrhea
and blood in stool. The weight loss is a major sign in colitis and that was
alleviated, too"
-
Bilberry extract shows colitis benefits: Animal study - Nutra USA,
6/2/10
-
Chronic colitis patients could benefit from resveratrol, says Spanish study
- Nutra USA 5/4/10 - "dietary administration of
resveratrol reduced the severity and extension of progressive chronic
colonic damage and also significantly counteracted the clinical signs
reducing the inflammatory process" - [Abstract]
- See
resveratrol products at Amazon.com.
-
Dietary supplementation of
resveratrol attenuates chronic colonic inflammation in mice - Eur J
Pharmacol. 2010 May 10;633(1-3):78-84 - "Our results
demonstrated that resveratrol group significantly attenuated the clinical signs
such as loss of body weight, diarrhea and rectal bleeding improving results from
disease activity index and inflammatory score. Moreover, the totality of
resveratrol-fed animals survived and finished the treatment while animals fed
with standard diet showed a mortality of 40%. Three weeks after DSS removal, the
polyphenol caused substantial reductions of the rise of pro-inflammatory
cytokines, TNF-alpha and IL-1beta and an increase of the anti-inflammatory
cytokine IL-10. Also resveratrol reduced prostaglandin E synthase-1 (PGES-1),
cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) proteins
expression, via downregulation of p38, a mitogen-activated protein kinases
(MAPK) signal pathway. We conclude that resveratrol diet represents a novel
approach to the treatment of chronic intestinal inflammation" - See
resveratrol products at Amazon.com.
-
Regular use of aspirin increases risk of Crohn's disease by 5 times, study
finds - Science Daily, 5/4/10 - "the researchers
discovered that those taking aspirin regularly for a year or more were
around five times more likely to develop Crohn's disease"
-
Olive oil could guard against developing ulcerative colitis - Science
Daily, 5/3/10 - "those with the highest intake of
oleic acid had a 90 per cent lower risk of developing the disease ... Oleic
acid seems to help prevent the development of ulcerative colitis by blocking
chemicals in the bowel that aggravate the inflammation found in this illness
... We estimate that around half of the cases of ulcerative colitis could be
prevented if larger amounts of oleic acid were consumed. Two-to-three
tablespoons of olive oil per day would have a protective effect"
-
Blueberries counteract intestinal diseases - Science Daily, 2/8/10 -
"blueberry fibre are important and can alleviate and
protect against intestinal inflammations, such as ulcerative colitis. The
protective effect is even better if the blueberries are eaten together with
probiotics ... probiotics proved to have a protective effect on the liver,
an organ that is often negatively impacted by intestinal inflammations"
- See
blueberry extract at Amazon.com.
-
Vitamin D supplements could fight Crohn's disease - Science Daily,
1/27/10 - "Vitamin D acts directly on the beta
defensin 2 gene, which encodes an antimicrobial peptide, and the NOD2 gene
that alerts cells to the presence of invading microbes. Both Beta-defensin
and NOD2 have been linked to Crohn's disease. If NOD2 is deficient or
defective, it cannot combat invaders in the intestinal tract ... Siblings of
patients with Crohn's disease that haven't yet developed the disease might
be well advised to make sure they're vitamin D sufficient" - See
vitamin D at Amazon.com.
-
Promising probiotic treatment for inflammatory bowel disease - Science
Daily, 1/21/10 - "Several recent studies have
identified butyric acid as a potential therapeutic agent for IBD. Some gut
bacteria produce butyric acid naturally in the intestines, but in IBD
patients some of these strains are heavily depleted. Trials in mice have
shown that injecting one such strain Faecalibacterium prausnitzii into the
digestive tract is effective at restoring normal levels of gut bacteria and
treating the symptoms of IBD. In addition, novel identified
butyrate-producing strains, such as Butyricicoccus pullicaecorum, have been
shown to exert similar effects"
-
Curcumin
suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta
and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children
and adults with inflammatory bowel disease - Br J Nutr. 2009 Nov 2:1-9 -
"We conclude that curcumin, a naturally occurring
food substance with no known human toxicity, holds promise as a novel
therapy in IBD" - See
curcumin products at Amazon.com.
-
Probiotics May Help Treat IBD Symptoms - WebMD, 10/29/09 -
"A new study shows treatment with the probiotic
Bacillus polyfermenticus reduced rectal bleeding, lessened tissue
inflammation, and promoted weight gain in mice with colitis. The mice also
had increased blood vessel growth in their intestinal lining, which is
important for healing damaged tissue. The probiotic also encouraged the
growth process of new blood vessels in laboratory tests with human
intestinal cells" - See
probiotics at Amazon.com.
-
Oxidized Form Of A Common Vitamin May Bring Relief For Ulcerative Colitis
- Science Daily, 10/1/09 - "Here's another reason
why you should take your vitamins. A new research report appearing in the
October 2009 print issue of the Journal of Leukocyte Biology suggests that
retinoic acid, the oxidized form of vitamin A, could be a beneficial
treatment for people suffering from ulcerative colitis and other irritable
bowel diseases"
-
Supplement Of Probiotics Provides A New Therapy For Ulcerative Colitis -
Science Daily, 2/27/09
-
New
Therapeutic Properties Of N-acetyl-L-cysteine Discovered - Science
Daily, 1/19/09 - "N-acetyl-L-cysteine (NAC) combined
with mesalamine produces a significant improvement in patients suffering
from ulcerative colitis ... N-acetyl-L-cysteine, is a drug normally used for
the treatment of chronic obstructive pulmonary disease (COPD) and to
minimize the effects of cold and flu. Its hepatic protective properties also
make this drug a useful tool in paracetamol intoxications ...
N-acetyl-L-cysteine reduced the negative effects caused by azathioprine, a
immunosuppressant of clinical use, on the liver" - See
n-acetyl cysteine at Amazon.com.
-
Probiotic May Help Treat Crohn's Disease - WebMD, 10/20/08 -
"A gut bacterium called F. prausnitzii may make a
good probiotic treatment for Crohn's disease"
-
Vitamin D Deficiency Common In Patients With IBD, Chronic Liver Disease
- Science Daily, 10/13/08 - "analyzed
vitamin D
levels of 504 inflammatory bowel disease patients ... almost 50 percent of
the patients were Vitamin D deficient at some point, with 11 percent being
severely deficient ... 92.4 percent of
chronic liver patients
had some degree of vitamin D deficiency and at least one third were severely
deficient. Severe vitamin D deficiency was more common among
cirrhotics" -
See
vitamin D at Amazon.com.
-
Patients With IBD, Chronic Liver Disease at Increased Risk of Vitamin D
Deficiencies - Doctor's Guide, 10/7/08 -
"conducted analysed vitamin D levels of 504 patients with IBD ...
researchers found almost 50% of the patients were vitamin D deficient at
some point, with 11% being severely deficient ... with hepatitis C virus
(HCV) ... 92.4% of the patients had some degree of vitamin D deficiency and
at least one-third was severely deficient" - See
vitamin D at Amazon.com.
-
Is
Probiotic Yakult Helpful In The Treatment Of Irritable Bowel Syndrome? -
Science Daily, 9/10/08 - "A pilot study was
undertaken to determine the effect of L. strain Shirota (Yakult®) on
intestinal fermentation patterns of IBS patients. After 6 week of treatment
with 1 x 65 mL dose of Yakult(R) daily, 9 of 14 patients (64%) completing
the study had reversal of ERBHAL, with the median time of first rise
increasing from 45 to 75 min (P = 0.03). Furthermore, symptoms improved in
those in whom ERBHAL was corrected"
- Suboptimal Vitamin
D Status Common in Patients With IBD - Medscape, 7/3/08
-
Prevalence of and risk factors for vitamin B(12) deficiency in patients with
Crohn's disease - Inflamm Bowel Dis. 2007 Sep 20 -
"Vitamin B(12) abnormalities are common in patients
with CD and patients with a prior ileal or ileocolonic resection are at
particular risk" - See
vitamin B12 at Amazon.com.
-
A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty
acid supplementation for inflammatory joint pain - Pain. 2007 Feb 28 -
"The results suggest that omega-3 PUFAs are an
attractive adjunctive treatment for joint pain associated with rheumatoid
arthritis, inflammatory bowel disease, and dysmenorrhea" - See Mega
Twin EPA at
iHerb.
- A Cure for Crohn's
Disease? - Dr. Weil, 2/6/07
-
Omega-3, quercitrin combo could ease bowel inflammation - Nutra USA,
6/5/06
-
Usefulness of omega-3 fatty acid supplementation in addition to mesalazine
in maintaining remission in pediatric Crohn's disease: A double-blind,
randomized, placebo-controlled study - World J Gastroenterol. 2005 Dec
7;11(45):7118-21 - "Enteric-coated omega-3 FAs in
addition to treatment with 5-ASA are effective in maintaining remission of
pediatric CD"
-
Essential fatty acid depletion in children with inflammatory bowel disease
- Scand J Gastroenterol. 2005 May;40(5):573-7 -
"Children with inflammatory bowel disease have a
high risk of n-6 PUFA depletion, which is related to disease activity"
-
Probiotics in the Management of Inflammatory Bowel Disease - Medscape,
7/18/05
-
Supplement May Ease Ulcerative Colitis - WebMD, 4/8/05
-
Nutritional Supplement Reduces Need For Traditional Ulcerative Colitis
Treatment - Doctor's Guide, 4/6/05
-
Calcium, Vitamin D Most Effective for Treatment of Crohn's-Related Bone Loss
- Doctor's Guide, 2/1/05 -
"calcium and vitamin D treatment alone can improve
bone mineral density (BMD) in Crohn's patients by 3 to 4 percent per year"
- Fish Oil Could
Help Crohn's Disease - WebMD, 12/10/04
-
Vitamin K status in patients with Crohn's disease and relationship to bone
turnover - Am J Gastroenterol. 2004 Nov;99(11):2178-85 -
"Vitamin K status of CD patients was lower than that
of the healthy controls. Furthermore, the rate of bone resorption in the CD
was inversely correlated with vitamin K status, suggesting that it might be
another etiological factor for CD-related osteopenia"
-
Inflammatory Bowel Disease Needs Fish/Cod Liver Oil - mercola.com,
11/28/04
-
Good Bacteria Trigger Proteins To Protect The Gut - Science Daily,
7/23/04 -
"Often antibiotics are used in such cases as Crohn's
disease, to eliminate gut bacteria. However, given our findings, the
beneficial role of commensal bacteria might have to be taken into account in
such treatments," - See
iHerb
probiotics products.
-
Porcine Whipworm Active Against Crohn's Disease - Doctor's Guide,
5/20/04
- Wormy Cocktail
Fights Crohn's Disease - WebMD, 5/19/04
-
Nutrition Q&A with Dan Lukaczer, N.D. - Natural Foods Merchandiser, 4/04
-
"Crohn’s subjects were supplemented with vitamin E
(800 IU) and C (1,000 mg) or placebo each day for four weeks ... These
patients were on medications and had what would be termed inactive or mildly
active disease"
- Porcine Whipworm Ova
Safe for Treatment of IBD - Medscape, 9/26/03
-
Can probiotic supplements help those with inflammatory bowel disease? -
Natural Foods Merchandiser, 9/03
-
Probiotic Therapy May Be Effective for Treating Ulcerative Colitis -
Doctor's Guide, 5/21/03 -
"adding a probiotic
with multiple strains and a high concentration of bacteria to the treatment
regimen may have the potential to stop this disease in its tracks and avoid
any treatment-related side effects" - See
iHerb
probiotics products.
- Beneficial Bacteria
Reduce Symptoms of Ulcerative Colitis
- New Hope Natural Media, 5/8/03 - See
iHerb
probiotics products.
-
Low Vitamin B6 Increases Thrombosis Risk In Inflammatory Bowel Disease -
Doctor's Guide, 1/29/03
-
Research Sharpens Interest in Cat's Claw - Natural Foods Merchandiser,
1/03 -
"The plant [cat's claw]
has been shown to be effective in treating a wide variety of
gastrointestinal conditions, including Crohn's disease, parasites,
diverticulitus, leaky bowel syndrome and ulcers"
-
Lactobacillus GG Not Helpful in Maintaining Remission of Crohn's Disease in
Children - Doctor's Guide, 10/25/02
-
New Research Validates Use Of Once-Daily High Dose "Good" Bacteria In
Patients With Recurrent Or Refractory Pouchitis - Doctor's Guide,
5/24/02 -
"We are excited about the results of this study
because a specific amount and type of probiotic
has demonstrated that it can dramatically improve patient outcome for
pouchitis," said lead investigator, Dr. Mimura. "Furthermore, because
pouchitis may be considered a model for other inflammatory bowel diseases
(IBD), these findings indicate we may have found an effective, inexpensive,
and widely available therapeutic treatment for various forms of IBD, such as
ulcerative colitis."
- Fighting
Inflammatory Bowel Disease, Antioxidants Show Promise in Reducing
Inflammation - WebMD, 4/10/01 -
"scientists say a combination of antioxidants and
drugs may help suppress the inflammation more than either approach could
alone ... Grisham and colleagues gave a powerful antioxidant to mice with
inflammatory bowel disease. The antioxidant, which was put in the animals'
water, helped raise the level of a naturally occurring antioxidant called
glutathione, he says. The amount of inflammation was significantly
reduced after the mice drank the antioxidant-spiked water"
-
The Probiotic Solution for Colitis - Nutrition Science News, 12/00
- Control Stress
and Eat Well: It May Help Your Gut - WebMD, 6/2/00 -
"I may also supplement them with calcium and vitamin
D, and with folic acid if they are on medication which interferes with folic
acid absorption."
-
Irritable Bowel Syndrome: A Gut Reaction - Nutrition Science News, 3/00
- Enteral Nutrition
Decreases Inflammation In Crohn's Patients - Doctor's Guide, 3/13/00
Other News:
-
Serum Triiodothyronine-to-thyroxine
(T3/T4) Ratio Predicts Therapeutic Outcome to Biological Therapies in
Elderly IBD Patients - Medscape, 2/1/21 -
"Baseline T3/T4 ratio was higher in patients with mucosal healing, as
compared with those without mucosal healing (P < 0.0001), regardless of the
disease type or biological drug (OR 6.4 [2.9–14.3] for each T3/T4 unit
increase, P < 0.0001). A cut point of 3.3 was identified as the optimal
threshold of baseline T3/T4 ratio for predicting mucosal healing, providing
78% sensitivity and 89% specificity (area under the ROC curve 0.88
[0.79–0.94]; positive and negative likelihood ratios 6.8 [2.9–15.9] and 0.3
[0.1–0.5] respectively) ... T3/T4 ratio seems a reliable tool for predicting
therapeutic outcome of biological therapy in elderly patients with IBD"
-
Yes, inflammatory bowel disease and celiac disease are linked - Science
Daily, 5/13/20
-
MR
enterography as effective as CT in diagnosing Crohn's disease, reduces
radiation exposure, study suggests - Science Daily, 6/15/11
-
Use
of naltrexone reduces inflammation in Crohn's patients, study suggests -
Science Daily, 5/19/11
-
C.
difficile increases risk of death six-fold in patients with inflammatory
bowel disease - Science Daily, 4/19/11 - "C.
difficile bacteria are present naturally in the gut in around two thirds of
children and 3 per cent of adults, but they do not cause problems in healthy
people. Broad spectrum antibiotics can cause problems by killing harmless
bacteria that usually reside in the gut, allowing C. difficile to flourish
and produce toxins that cause diarrhea and fever. The infection is rarely
fatal in people who are not already severely ill or elderly; a review
published in 2010 estimated the overall mortality rate for patients with C.
difficile to be 6 per cent ... IBD patients who contract C. difficile in
hospital are six times more likely to die in hospital than patients who are
admitted for IBD alone. In the patients followed in the study, the mortality
rate for IBD patients with C. difficile at 30 days was 25 per cent, compared
with 3 per cent for patients with IBD alone ... IBD patients with C.
difficile also stay in hospital for longer, with a median length of stay of
26 days compared with five days, and are almost twice as likely to need
gastrointestinal surgery ... At St. George's Hospital, we have seen a 70 per
cent reduction in hospital-acquired infections after implementing a range of
control measures, such as careful handwashing and reduced use of broad
spectrum antibiotics"
-
Probiotic bacteria could help treat Crohn's disease - Science Daily,
3/31/11
-
Inflammatory bowel disease can cause post traumatic stress, say doctors
- Science Daily, 12/1/10
-
Low
bone mineral density common in children and teenagers with inflammatory
bowel disease - Science Daily, 8/23/10
-
IBD Flare-ups May Increase Blood Clot Risk - WebMD, 2/9/10
-
Blood in Stool, Other
Factors Suggest Crohn's Disease Over Intestinal Tuberculosis - Medscape,
2/5/10
-
Some IBD Drugs May Raise Skin Cancer Risk - WebMD, 10/26/09
-
Ulcerative Colitis Treatment Reduces Need For Surgery By Almost Half, Study
Suggests - Science Daily, 10/1/09
-
Living With Crohn's Disease: After Ups and Downs, Surgery Might Work -
washingtonpost.com, 1/27/09
-
Crohn's Disease Surgeries Make Steady Advances - Science Daily, 11/18/08
-
FDA OKs New Crohn's Disease Drug Cimzia - WebMD, 4/23/08
-
Combined
Immunosuppression May Be Helpful in Recent-Onset Crohn's Disease -
Medscape, 2/26/08
-
Do
Patients With Inflammatory Bowel Disease Receive Optimal Care? - Science
Daily, 2/22/08
-
Safer And More Effective Way To Treat Crohn's Disease - Science Daily,
2/21/08
-
FDA Approves TYSABRI® (natalizumab) for the Treatment of Moderate-to-Severe
Crohn's Disease - Doctor's Guide, 1/14/08
-
Increased Mortality in
Crohn's Disease Depends on Medications Used - Medscape, 1/7/08
-
How
Bacteria In Cows' Milk May Cause Crohn's Disease - Science Daily,
12/10/07
-
Infliximab Cuts Steroid Use in IBD Patients - Doctor's Guide, 10/31/07
-
Threshold For Bowel Surgery May Be Too High, Warn Experts - Science
Daily, 10/31/07
-
New
Treatment Is Effective Strategy In IBD Patients, Study Suggests -
Science Daily, 10/29/07
-
Remicade Cuts Need for Colon Removal Surgery - WebMD, 10/16/07
-
Capsule Endoscopy Turning Up Undiagnosed Cases Of Crohn's Disease -
Science Daily, 10/16/07
-
Capsule Endoscopy Diagnoses More Crohn's Disease Recurrence After Surgery
Than Colonoscopy - Science Daily, 9/26/07
-
Biologics Valuable Treatment Option For Patients With Inflammatory Bowel
Disease - Science Daily, 7/25/07
-
New Drug May Help Treat Crohn's Disease - WebMD, 7/18/07
-
New
Treatment For Crohn's Disease Appears Promising - Science Daily, 5/25/07
-
The Safety of Extended Use of Infliximab for Crohn's Disease - Doctor's
Guide, 5/22/07
-
New
Prevention, Treatment Methods For Patients With Painful Bowel Inflammation
- Science Daily, 5/22/07
-
Smoking Influences Crohn's Disease - Science Daily, 5/6/07
-
Researchers Identify New Therapy for Patients with Crohn's Disease -
Doctor's Guide, 5/3/07
-
New
Therapy For Patients With Crohn's Disease Identified - Science Daily,
5/1/07
-
Inflammatory Bowel Disease Linked To Nerve Damage - Science Daily,
4/23/07
-
FDA Approves New Treatment For Crohn's Disease - Doctor's Guide, 2/28/07
-
Decades-Long Study Will Help Improve Surgery for Crohn's Disease -
Doctor's Guide, 2/21/07
-
Withdrawal Drug Offers Symptom Relief To Crohn's Sufferers, Study Shows
- Science Daily, 2/4/07
-
MedInsight(SM) Announces Clinical Trial Results of Low-dose Naltrexone;
Potential Breakthrough for Crohn's Disease Patients - Doctor's Guide,
1/31/07
-
Natalizumab Shows Potential in Treating Moderate-to-Severe Crohn's Disease
- Doctor's Guide, 10/30/06
-
Natalizumab Maintains Remission for 2 Years in Patients With Moderately to
Severely Active Crohn's Disease and in Those With Prior Infliximab Exposure
- Doctor's Guide, 10/30/06
-
Sustained Clinical Remission and Response in Crohn's Disease With Extended
Adalimumab Therapy - Doctor's Guide, 10/30/06
-
Stubborn Ulcerative Colitis Responds to Infliximab - Doctor's Guide,
9/11/06
-
Risk of Infertility in Women Triples After Common Inflammatory Bowel Disease
- Doctor's Guide, 6/14/06
-
Budesonide Capsules Recommended by American Gastroenterology Association as
First-Line Therapy for the Treatment of Mild-to-Moderate Crohn's Disease
- Doctor's Guide, 6/5/06
-
Asacol Induced Rapid Mucosal Healing in Ulcerative Colitis Patients -
Doctor's Guide, 5/30/06
-
Study Shows Novel Therapy May Produce Early Remission in Crohn's Patients
- Doctor's Guide, 5/30/06
-
New Options in Medical Treatment of Ulcerative Colitis - Doctor's Guide,
5/29/06
-
Adalimumab Effective in Active Crohn's Disease - Doctor's Guide, 5/29/06
-
Certolizumab Effective for Active Crohn's Disease - Doctor's Guide,
5/29/06
-
Natalizumab Achieves Sustained Response and Remission of Crohn's Disease
- Doctor's Guide, 5/29/06
-
New
Compounds Fight Chronic Symptoms Of Bowel Disorders - Science Daily,
5/23/06
-
FDA Approves Remicade (infliximab) as First and Only Biologic Treatment for
Children With Active Crohn's Disease - Doctor's Guide, 5/22/06
-
Viagra May Help Crohn's Disease - WebMD, 2/23/06
- CT vs Standard
Enteroclysis May Be Superior for Evaluating Crohn's Disease
- Medscape, 2/3/06
-
Prescription Painkillers Effective in Patients With Dormant Inflammatory
Bowel Disease - Doctor's Guide, 2/2/06
-
Improved Diagnostic Technology for Crohn's Disease - Doctor's Guide,
1/31/06
-
Landmark Trials Demonstrate Benefits of Remicade (Infliximab) in Patients
With Ulcerative Colitis - Doctor's Guide, 12/8/05
-
Remicade Treats Ulcerative Colitis - WebMD, 12/7/05
-
Ulcerative Colitis Patients Inadequately Screened for Colorectal Cancer
- Doctor's Guide, 11/22/05
-
Infliximab Associated with Lower Hospitalization Rates in Ulcerative Colitis
- Doctor's Guide, 11/9/05
-
Mild to Moderate Ulcerative Colitis Responds to Once-Daily Mesalamine
Formulation - Doctor's Guide, 11/3/05
-
Given Imaging Announces Two Clinical Studies Show PillCam SB Detects Tumors
and Crohn's Disease Not Found By Other Tests - Doctor's Guide, 11/3/05
-
Abbott's Humira (Adalimumab) Shows Promising Results in Long-Term Treatment
of Crohn's Disease, According to Phase III Study - Doctor's Guide,
10/31/05
-
Remicade Data Show Promise for Children with Crohn's Disease - Doctor's
Guide, 10/25/05
-
Certolizumab Pegol Safely Maintains Response and Remission after Induction
in Active Crohn's Disease - Doctor's Guide, 10/21/05
-
5-Aminosalicylic Acid and Risk of Colorectal Polyps in Patients with
Inflammatory Bowel Disease - Doctor's Guide, 10/21/05
-
Once-Daily, High-Dose Mesalazine Well Tolerated and Effective for Induction
of Remission in Mild-to-Moderate Ulcerative Colitis - Doctor's Guide,
10/20/05
-
Better Outcome with Potent Top-Down Induction Therapy in Recent Onset
Crohn's Disease - Doctor's Guide, 10/20/05
-
Adalumimab Maintains Response and Remission in Patients with Crohn's -
Doctor's Guide, 10/19/05
-
Infliximab Maintenance Therapy Induces and Maintains Endoscopic Healing and
Prevents Surgery in Patients with Active Crohn's Disease - Doctor's
Guide, 10/19/05
-
Infliximab Therapy Effective for Active Ulcerative Colitis: Presented at
WCOG - Doctor's Guide, 9/19/05
-
FDA Approves Remicade (infliximab) as First and Only Biologic to Treat
Ulcerative Colitis - Doctor's Guide, 9/16/05
-
Adalimumab Offers Treatment Option for Crohn's Disease: Presented at WCOG
- Doctor's Guide, 9/15/05
-
Steroid May Delay Return of Crohn's Disease - WebMD, 9/15/05
-
Mesalamine Once Daily As Good As Twice Daily in Mild to Moderate Ulcerative
Proctitis - Doctor's Guide, 9/15/05
-
Budesonide Provides Lasting Relief for Crohn's Disease Patients -
Doctor's Guide, 9/14/05
-
People With Inflammatory Bowel Disease More Likely to Suffer From
Debilitating Respiratory and Nerve Disorders - Doctor's Guide, 9/1/05
-
Drug
Therapy Eases Symptoms In Many Crohn's Disease Patients - Science Daily,
6/7/05
- Expert Commentary
-- Continuing Challenges in the Management of Crohn's Disease
- Medscape, 5/26/05
-
Bone Marrow Drug May Help Crohn's Disease - WebMD, 5/25/05
-
Tegaserod (Zelnorm) Improves Quality Of Life Measures Among IBS with
Constipation Patients - Doctor's Guide, 5/20/05
-
Adalimumab Effective for Crohn's Disease in 6-Month Open-Label Study -
Doctor's Guide, 5/20/05
-
Extract of Patient's Own Colonic Mucosal Proteins Effective in Crohn's
Disease, Study Finds - Doctor's Guide, 5/19/05
-
Adalimumab Shows Promise for Treatment of Crohn's Disease - Medscape,
5/19/05
-
Remicade May Treat Ulcerative Colitis Symptoms - WebMD, 5/18/05
-
Infliximab Effective for Ulcerative Colitis - Doctor's Guide, 5/17/05
-
New
Treatment For Inflammatory Bowel Disease - Science Daily, 3/18/05
- Humira Relieves
Crohn's Disease Symptoms - WebMD, 2/1/05
-
FDA Grants Remicade (Infliximab) Fast Track Designation For Treatment Of
Active Ulcerative Colitis - Doctor's Guide, 12/16/04
-
Crohn's Disease Treatment Shows Promise In Clinical Trial - Science
Daily, 11/18/04
-
Crohn's Disease Treatment Shows Promise In Clinical Trial - Science
Daily, 11/15/04
-
Infliximab Reduces Pain From Crohn's Disease - Doctor's Guide, 11/4/04
-
Colitis May Not Lead to Cancer - Doctor's Guide, 11/3/04
- Pregnancy and
IBD Treatment Safe - WebMD, 11/3/04
-
Natalizumab Achieves Sustained Clinical Response and Remission in Crohn's
Disease - Doctor's Guide, 9/30/04
-
Oral Tacrolimus Shows Efficacy for Moderate/Severe Ulcerative Colitis -
Doctor's Guide, 9/30/04
-
Study Data Confirm Long-Term Safety of Remicade (Infliximab) in Crohn's
Disease - Doctor's Guide, 9/29/04
-
Remicade (Infliximab) Appears to Rapidly and Significantly Reduce Pain in
Patients with Crohn's Disease - Doctor's Guide, 9/29/04
-
Red Meat And Alcohol Bowel Risk - Science Daily, 9/17/04 -
"A diet high in red meat and alcohol may triple the
risk of relapse in patients with the inflammatory bowel disease ulcerative
colitis"
- Bug May Cause
Crohn's Disease - WebMD, 9/16/04
- Study: Hold
the Meat to Avoid Colitis - WebMD, 9/13/04
-
Fatty Acid Supplement to IV Nutrition May Reduce Complications in Preemies
and Patients With Crohn's - Doctor's Guide, 6/2/04
-
Natalizumab (Antegren) Helps Maintain Clinical Response in Crohn's Disease
- Doctor's Guide, 5/20/04
- Adalimumab and
Natalizumab Induce Remission in Some Crohn's Disease Patients -
Medscape, 5/20/04
- Immune System
Drugs Help IBD - WebMD, 5/19/04
-
Therapeutic Effects of Sargramostim (Leukine) Persist After Treatment
Discontinuation in Patients With Moderately-to-Severely Active Crohn's
Disease - Doctor's Guide, 5/19/04
-
Crohn’s Disease: Treating Fistulas and Severe Symptoms - Physician's
Weekly, 5/17/04
-
Severity of Inflammation in Ulcerative Colitis Linked to Increased Risk of
Colorectal Neoplasia - Doctor's Guide, 3/1/04
- Remicade Fights
Crohn's Disease Complications - WebMD, 2/26/04
-
Maintenance Infliximab More Effective than Placebo in Sustaining Response in
Fistulizing Crohn's Disease Responsive to Induction Infliximab -
Doctor's Guide, 2/26/04
-
IBD and Depression: Complicating Matters - Physician's Weekly, 2/23/04
-
Probiotic VSL#3 Maintains Remission in 85 Percent Of Ulcerative Colitis
Patients with Pouchitis, Study Confirms - Doctor's Guide, 1/5/04
- Does Cold Food
Cause Crohn's? - WebMD, 12/11/03
-
Bone Loss in Patients with Crohn's Disease Not Due to Corticosteroid Use
- Doctor's Guide, 11/28/03
-
Daily Budesonide 6 mg Prolongs Time to Relapse in Crohn's Disease -
Doctor's Guide, 11/11/03
-
Bupropion May Aid Patients With Inflammatory Bowel Disease - Doctor's
Guide, 11/10/03
-
Budesonide Rapidly Induces Clinical Remission in Collagenous Colitis -
Doctor's Guide, 11/7/03
-
Anaemic Inflammatory Bowel Disease Patients Can Receive Iron Treatment -
Doctor's Guide, 11/4/03
-
Worm Eggs Help IBD - Physician's Weekly, 11/3/03
-
Sargramostim A Promising Treatment For Crohn's Disease - Doctor's Guide,
10/27/03
-
Infliximab Therapy Predisposes Patients to Serious Opportunistic Infection
- Doctor's Guide, 10/22/03
-
Crohn's Disease Diagnosed By Video Capsule Endoscopy - Doctor's Guide,
10/15/03
- Parasitic Worms
Ease IBD - WebMD, 9/24/03
-
MAP Bacteria Linked to Crohn’s - Physician's Weekly, 9/1/03
-
Increased Awareness Needed Regarding Smoking Risks in Crohn's Disease -
Doctor's Guide, 7/30/03
-
Epidermal Growth Factor Enemas Show Efficacy in Treating Left-Sided
Ulcerative Colitis or Proctitis - Doctor's Guide, 7/25/03
- Faster
Ulcerative Colitis Treatment - Doctor's Guide, 7/23/03
- Infliximab Induces
Positive ANA in More Than Half of Crohn's Patients - Medscape, 7/11/03
-
Even Mild Inflammatory Bowel Disease Adversely Affects Psychosocial
Functioning of Children and Families - Doctor's Guide, 5/23/03
-
Natalizumab Improves Quality of Life for Patients with Crohn's Disease -
Doctor's Guide, 5/24/03
-
Apheresis Device Succeeds in Refractory Ulcerative Colitis Patients -
Doctor's Guide, 5/23/03
-
Crohn's Fatigue Caused by Both Psychological and Physical Factors -
Doctor's Guide, 5/19/03
-
Infliximab May Reduce Need For Steroid Use In Children With Crohn's Disease
- Doctor's Guide, 5/8/03
-
Aminosalicylates, Corticosteroids in Monotherapy or in Combination Used Most
Frequently Against Crohn's Disease in Spain - Doctor's Guide, 4/2/03
-
Sodium Fluoride, Ibandronate Effective In Osteoporotic Women With Crohn's
Disease - Doctor's Guide, 3/26/03
- Biopsy of Gastric
Antrum Helps Diagnose Crohn's Disease - Medscape, 3/24/03
-
Patients With Chronic Active Crohn's Disease May Respond To 6-Thioguanine
- Doctor's Guide, 3/23/03
- Wireless Capsule
Endoscopy Helps Diagnose Crohn's Disease - Medscape, 3/17/03
-
Crohn's Disease Recurrence Unimproved By Higher Mesalazine Dosage -
Doctor's Guide, 3/14/03
-
Alpha1-Antitrypsin Clearance Indicates Relapse In Crohn's Disease -
Doctor's Guide, 3/10/03
-
Laparoscopic Ileocolectomy Safe And Effective For Primary Crohn Disease
- Doctor's Guide, 2/27/03
-
Gadolinium Enhanced MRI with PEG Enhances Crohn's Disease Diagnosis -
Doctor's Guide, 2/20/03
- Crohn's Drug
Remicade Works Longer With Immune-Suppressing Drugs - WebMD, 2/12/03
-
Budesonide An Alternative To Prednisone In Paediatric Crohn's Disease -
Doctor's Guide, 2/6/03
- Laparoscopy Best for
Ileocolectomy in Crohn's Disease - Doctor's Guide, 1/27/03
-
Remicade (Infliximab) Granted Priority Review by FDA for Use in Maintaining
Fistula Closure in Fistulizing Crohn's Disease - Doctor's Guide, 1/7/03
- New Drug
[natalizumab] Fights MS and Crohn's Disease - WebMD, 1/2/03
-
Measurement of Mucosal IL-8 May Help Predict Response to Granulocytapheresis
in Patients with Ulcerative Colitis - Doctor's Guide, 11/27/02
- Appendectomy Protects
Against Inflammatory Bowel Disease - Medscape, 11/15/02
- Immune-Enhancer
GM-CSF Helpful in Crohn's Disease - Medscape, 11/8/02
- Chemo Drug
Improves Crohn's Symptoms - WebMD, 11/7/02
-
Pregnancy Safe In Women With Ileal Pouch-Anal Anastomosis - Doctor's
Guide, 11/6/02
-
No Increase in Strictures with Infliximab in Crohn's Disease Patients -
Doctor's Guide, 10/24/02
-
Budesonide Preserves Bone Mass in Crohn's Disease Patients - Doctor's
Guide, 10/24/02
-
Peptide Coherin May Induce Clinical Remission in Crohn's Disease -
Doctor's Guide, 10/24/02
-
Case Report Suggests Infliximab May Be Useful in Ulcerative Colitis -
Doctor's Guide, 10/23/02
-
High Doses of Alicaforsen Appear Safe, Effective in Active Crohn's Disease
- Doctor's Guide, 10/22/02
-
Infliximab Treatment Less Effective In Crohn's Disease Patients With
Intestinal Strictures - Doctor's Guide, 10/21/02
-
Once-A-Day Dosing With Mesalamine Improves Adherence In Quiescent Ulcerative
Colitis - Doctor's Guide, 10/21/02
-
5-Lipoxygenase Not Linked To Inflammatory Bowel Disease Activity -
Doctor's Guide, 10/8/02
-
Magnifying Colonoscopy Useful For Evaluating Ulcerative Colitis -
Doctor's Guide, 10/7/02
-
Diagnosing, Managing Enterovesical Fistula In Crohn's Patients -
Doctor's Guide, 9/27/02
-
No Link Between Azathioprine/6-Mercaptopurine Before Proctocolectomy and
Postoperative Complications - Doctor's Guide, 9/23/02
-
Laparoscopic Surgery Safe For Management Of Crohn's Disease With Complicated
Fistulas - Doctor's Guide, 8/27/02
-
Degree of Lamina Propria Inflammation Can Guide Collagenous Colitis
Treatment - Doctor's Guide, 8/16/02
-
Hyperplastic Polyps In Ulcerative Colitis May Have Neoplastic Potential
- Doctor's Guide, 8/8/02
-
Dietary Fat Composition in Enteric Diets Influences Crohn's Disease
Remission - Doctor's Guide, 7/30/02
- Dietary Fat
Composition May Influence Remission in Crohn's Disease - Medscape,
7/30/02
-
Remicade (Infliximab) is The First Biologic Therapy Approved by the FDA to
Induce and Maintain Clinical Remission in Patients With Moderate- to- Severe
Crohn's Disease - Doctor's Guide, 7/2/02
-
Fistulas in Crohn's Respond to Long-Term Infliximab - Doctor's Guide,
5/23/02
-
Maintenance on Infliximab Gives Better QOL in Crohn's - Doctor's Guide,
5/23/02
-
Interferon Beta-1a Promising in Ulcerative Colitis - Doctor's Guide,
5/22/02
-
Thalidomide Shows Promise in Controlling Gastrointestinal Bleeding and
Lowering Vascular Endothelial Growth Factor - Doctor's Guide, 5/21/02
-
Irritable Bowel Disease May Have Unique Histology in Kids - Doctor's
Guide, 5/21/02
-
Diet Avoids Steroid Use in Children with Crohn's Disease - Doctor's
Guide, 5/20/02
- Long-Term
Remicade Use Helps Crohn's - WebMD, 5/2/02 - See
Remicade.
-
Infliximab [Remicade] Has Long-Term Benefit For Crohn's Disease -
Doctor's Guide, 5/2/02
-
Analysis Confirms Association Between Crohn's Disease and CARD15 Mutations
- Doctor's Guide, 4/5/02
-
Abdominal Ultrasound Scans Help Characterize Inflammatory Bowel Disease
- Doctor's Guide, 4/1/02
-
Impact Of Obesity On Crohn's Disease - Doctor's Guide, 3/22/02
-
Dealing With "Difficult To Manage" Inflammatory Bowel Disease Patients -
Doctor's Guide, 3/13/02
-
Budesonide Effective For Mild/Moderate Paediatric Crohn's Disease -
Doctor's Guide, 2/7/02
- Cytokine Genotyping May
Prove Useful in Patients With Crohn's Disease - Doctor's Guide, 2/6/02
-
Growth Hormone Benefits Children With Steroid-Dependent Inflammatory Bowel
Disease - Doctor's Guide, 2/5/02
- Study Suggests Link
Between Anxiety and Ulcerative Colitis Flares - Doctor's Guide, 2/4/02
-
High Prevalence Of Musculoskeletal Manifestations In Inflammatory Bowel
Disease - Doctor's Guide, 12/20/01
-
Immune Thrombocytopenic Purpura Linked To Inflammatory Bowel Disease -
Doctor's Guide, 12/19/01
- Results of Infliximab as
Maintenance Therapy in Treatment of Crohn’s Disease Presented - Doctor's
Guide, 10/22/01
- Remicade Puts
Crohn's Disease Into Remission - WebMD, 10/22/01 - see
Remicade
-
FDA Approves New Drug [Entocort EC] For Crohn's Disease - Intelihealth,
10/4/01
- FDA Approves Entocort EC
(Budesonide) For Crohn's Disease - Doctor's Guide, 10/3/01
- Patients Can Take
Charge of Ulcerative Colitis - WebMD, 9/24/01
- Quitting Smoking Reduces
Risk of Recurrence in Crohn's Disease - Doctor's Guide, 6/7/01
- Remicade (Infliximab) Does
Not Eliminate Need For Surgery In Fistulizing Crohn's Disease Patients -
Doctor's Guide, 6/7/01
- Budesonide Capsules Safe
And Effective For Crohn's Disease - Doctor's Guide, 5/25/01
- Study shows infliximab can
maintain long-term remissions in Crohn's disease - Doctor's Guide,
5/21/01
-
No Quality Of Life Difference Between Strictureplasty And Resection For
Crohn's Disease - Doctor' Guide, 4/19/01
- Fight the Fire of
Crohn's Disease: Quit Smoking! - WebMD, 4/16/01 -
"quitting seems to snuff out the painful flare-ups
of this inflammatory bowel disease, a disease that is not only associated
with pain, but also with diarrhea, abdominal cramps, fever, fatigue, and
rectal bleeding"
- Antegren (Natalizumab)
Promising Treatment For Multiple Sclerosis, Crohn's Disease - Doctor's
Guide, 1/23/01
- Infliximab Safe, Effective
In Children With Persistent, Severe Crohn's Disease - Doctor's Guide,
11/1/00
- Infliximab Reduces
Reliance On Surgery And Hospital Services For Crohn's Disease - Doctor's
Guide, 10/20/00
- Steroids Widely Used to
Treat Crohn's Disease, Despite Serious Side Effects - Doctor's Guide,
10/13/00
- CBP-1011 Showing Promise
In Treatment Of Mild Or Moderate Crohn's Disease - Doctor's Guide,
9/12/00
- Most Pain
Relievers Unsafe for Inflammatory Bowel Disease - WebMD, 9/7/00
- New Irritable
Bowel Disease Treatments Aim for the Gut - WebMD, 8/24/00
- Modest Efficacy For
Controlled Ileal-Release Budesonide In Pediatric Crohn's Disease -
Doctor's Guide, 8/10/00
- Rapid Remission Of
Pediatric Crohn's Disease Without Steroids - Doctor's Guide, 8/10/00
- Infliximab May Offer
Healing For Youths With Crohn's Disease - Doctor's Guide, 8/7/00
- Effects Of Drug Treatment
On Crohn's Disease Recurrence After Strictureplasty - Doctor's Guide,
6/30/00
- Two Drugs May
Keep Symptoms at Bay Better and Longer - WebMD, 5/31/00
-
Growth Hormone Improves Symptoms In Crohn's Disease Patients -
Intelihealth, 6/1/00
- Thalomid (Thalidomide),
TNF-alpha Modulators Show Promise in Inflammatory Bowel Disease -
Doctor's Guide, 5/25/00
- Remicade (Infliximab) May
Enable Patients With Crohn's To Discontinue Steroids - Doctor's Guide,
5/25/00
- Multiple Risk Factors
Behind Bone Loss In Crohn's Disease - Doctor's Guide, 5/23/00
- Enteral Nutrition
Decreases Inflammation In Crohn's Patients - Doctor's Guide, 3/13/00
- Crohn’s Not Caused By
Measles Virus - Doctor's Guide, 1/25/00
- Steroid Dosages May Be
Decreased When Thalomid Is Added In Crohn’s Patients - Doctor's Guide,
11/30/99
- Infliximab Clinical
Experience Mimics Pre-Approval Experience - Doctor's Guide, 10/20/99
- Repeat Use of Remicade
Elicits Crohn’s Disease Symptom Remission - Doctor's Guide, 9/30/99
- Elevated Homocysteine
Found In Patients With IBD - Doctor's Guide, 9/2/99
- Crohn’s Patients Respond To
RHIL-11 - Doctor's Guide, 5/20/99
- Thalomid Active In Treating
Crohn's Disease - Doctor's Guide, 5/19/99
- Remicade Effective For
Serious Complication Of Crohn's Disease - Doctor's Guide, 5/6/99
- Thalomid Receives FDA
Orphan Drug Designation For Crohn's Disease - Doctor's Guide, 4/15/99
- Remicade Now Available In
U.S. For Crohn's Disease - Doctor's Guide, 10/13/98
- FDA Approves Remicade For
Crohn's Disease - Doctor's Guide, 8/24/98
- Crohn's Drug Shown To
Maintain Remission And Avoid Steroid Use - Doctor's Guide, 6/10/98
- New Monoclonal Antibody
Effective Treatment For Crohn's Disease Therapy - Doctor's Guide,
5/13/97
|
|